| [1] | 
																						 
											  Sung H, Ferlay J, Siegel RL, et al.  Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660. 
											 												 
																									doi: 10.3322/caac.21660
																																			 											 | 
										
																													
																						| [2] | 
																						 
											  Xia C, Dong X, Li H, et al.  Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl), 2022, 135(5): 584-590. DOI: 10.1097/CM9.0000000000002108. 
											 												 
																									doi: 10.1097/CM9.0000000000002108
																																			 											 | 
										
																													
																						| [3] | 
																						 
											  Salimzadeh H, Lindskog EB, Gustavsson B, et al.  Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival[J]. BMC Cancer, 2020, 20(1): 409. DOI: 10.1186/s12885-020-06924-z. 
											 												 
																									doi: 10.1186/s12885-020-06924-z
																																					pmid: 32397974
																							 											 | 
										
																													
																						| [4] | 
																						 
											  Chan JCY, Diakos CI, Chan DLH, et al.  A longitudinal investigation of inflammatory markers in colorectal cancer patients perioperatively demonstrates benefit in serial remeasurement[J]. Ann Surg, 2018, 267(6): 1119-1125. DOI: 10.1097/SLA.0000000000002251. 
											 												 
																									doi: 10.1097/SLA.0000000000002251
																																					pmid: 28394869
																							 											 | 
										
																													
																						| [5] | 
																						 
											  Dolan RD, McSorley ST, Park JH, et al.  The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores[J]. Br J Cancer, 2018, 119(1): 40-51. DOI: 10.1038/s41416-018-0095-9. 
											 												 
																									doi: 10.1038/s41416-018-0095-9
																																			 											 | 
										
																													
																						| [6] | 
																						 
											  Chen JH, Zhai ET, Yuan YJ, et al.  Systemic immune-inflammation index for predicting prognosis of colorectal cancer[J]. World J Gastroenterol, 2017, 23(34): 6261-6272. DOI: 10.3748/wjg.v23.i34.6261. 
											 												 
																									doi: 10.3748/wjg.v23.i34.6261
																																			 											 | 
										
																													
																						| [7] | 
																						 
											  Verter E, Berger Y, Perl G, et al.  Neutrophil-to-lymphocyte ratio predicts recurrence pattern in patients with resectable colorectal liver metastases[J]. Ann Surg Oncol, 2021, 28(8): 4320-4329. DOI: 10.1245/s10434-021-10000-6. 
											 												 
																									doi: 10.1245/s10434-021-10000-6
																																			 											 | 
										
																													
																						| [8] | 
																						 
											  Thanikachalam K, Khan G. Colorectal cancer and nutrition[J]. Nutrients, 2019, 11(1): 164. DOI: 10.3390/nu11010164. 
											 												 
																									doi: 10.3390/nu11010164
																																			 											 | 
										
																													
																						| [9] | 
																						 
											  Yamamoto T, Kawada K, Obama K. Inflammation-related biomar-kers for the prediction of prognosis in colorectal cancer patients[J]. Int J Mol Sci, 2021, 22(15): 8002. DOI: 10.3390/ijms22158002. 
											 												 
																									doi: 10.3390/ijms22158002
																																			 											 | 
										
																													
																						| [10] | 
																						 
											  Tian G, Li G, Guan L, et al.  Pretreatment albumin-to-alkaline phosphatase ratio as a prognostic indicator in solid cancers: a meta-analysis with trial sequential analysis[J]. Int J Surg, 2020, 81: 66-73. DOI: 10.1016/j.ijsu.2020.07.024. 
											 												 
																									doi: S1743-9191(20)30559-8
																																					pmid: 32745716
																							 											 | 
										
																													
																						| [11] | 
																						 
											  An L, Yin WT, Sun DW. Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible?[J]. BMC Cancer, 2021, 21(1): 247. DOI: 10.1186/s12885-021-07921-6. 
											 												 
																									doi: 10.1186/s12885-021-07921-6
																																					pmid: 33685425
																							 											 | 
										
																													
																						| [12] | 
																						 
											  Wang F, He W, Jiang C, et al.  Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer[J]. BMC Cancer, 2018, 18(1): 1102. DOI: 10.1186/s12885-018-4842-3. 
											 												 
																									doi: 10.1186/s12885-018-4842-3
																																					pmid: 30419863
																							 											 | 
										
																													
																						| [13] | 
																						 
											  Cassetta L, Fragkogianni S, Sims AH, et al.  Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets[J]. Cancer Cell, 2019, 35(4): 588-602, e10. DOI: 10.1016/j.ccell.2019.02.009. 
											 												 
																									doi: S1535-6108(19)30104-7
																																					pmid: 30930117
																							 											 | 
										
																													
																						| [14] | 
																						 
											  Kemp SB, Steele NG, Carpenter ES, et al.  Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages[J]. Life Sci Alliance, 2021, 4(6): e202000935. DOI: 10.26508/lsa.202000935. 
											 												 
																									doi: 10.26508/lsa.202000935
																																			 											 | 
										
																													
																						| [15] | 
																						 
											  Sasaki A, Kai S, Endo Y, et al.  Prognostic value of preoperative peripheral blood monocyte count in patients with colorectal liver metastasis after liver resection[J]. J Gastrointest Surg, 2007, 11(5): 596-602. DOI: 10.1007/s11605-007-0140-0. 
											 												 
																									doi: 10.1007/s11605-007-0140-0
																																					pmid: 17468918
																							 											 | 
										
																													
																						| [16] | 
																						 
											  Chan JC, Chan DL, Diakos CI, et al.  The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer[J]. Ann Surg, 2017, 265(3): 539-546. DOI: 10.1097/SLA.0000000000001743. 
											 												 
																									doi: 10.1097/SLA.0000000000001743
																																					pmid: 27070934
																							 											 | 
										
																													
																						| [17] | 
																						 
											  Li Y, Jia H, Yu W, et al.  Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection[J]. Int J Cancer, 2016, 139(1): 220-231. DOI: 10.1002/ijc.30071. 
											 												 
																									doi: 10.1002/ijc.30071
																																					pmid: 26933932
																							 											 | 
										
																													
																						| [18] | 
																						 
											  Suzuki Y, Okabayashi K, Hasegawa H, et al.  Comparison of preoperative inflammation-based prognostic scores in patients with colorectal cancer[J]. Ann Surg, 2018, 267(3): 527-531. DOI: 10.1097/SLA.0000000000002115. 
											 												 
																									doi: 10.1097/SLA.0000000000002115
																																					pmid: 27984214
																							 											 |